BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Kodak
KODK
$485M
| $59.2K | ﹤0.01% |
12,757
-9,912
| -44% | -$46K |
|
2702
iRadimed
IRMD
$945M
| $59.2K | ﹤0.01% |
1,744
-1,507
| -46% | -$51.1K |
|
2703
Pure Cycle
PCYO
$272M
| $59.2K | ﹤0.01% |
5,615
+2,798
| +99% | +$29.5K |
|
2704
OR Royalties Inc.
OR
$6.75B
| $59.2K | ﹤0.01% |
5,859
| – | – |
|
|
LBC
2705
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $59K | ﹤0.01% |
4,521
-262
| -5% | -$3.42K |
|
|
EIGR
2706
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $58.6K | ﹤0.01% |
310
+209
| +207% | +$39.5K |
|
2707
KalVista Pharmaceuticals
KALV
$746M
| $58.6K | ﹤0.01% |
5,958
+4,189
| +237% | +$41.2K |
|
2708
FVCBankcorp
FVCB
$244M
| $58.6K | ﹤0.01% |
3,889
+3,730
| +2,346% | +$56.2K |
|
|
PTR
2709
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $58.3K | ﹤0.01% |
1,250
-1,366
| -52% | -$63.7K |
|
2710
MeiraGTx Holdings
MGTX
$617M
| $57.3K | ﹤0.01% |
7,568
+3,319
| +78% | +$25.1K |
|
|
CYBE
2711
DELISTED
Cyberoptics Corp
CYBE
| $57K | ﹤0.01% |
1,631
+1,610
| +7,667% | +$56.3K |
|
|
SPLP
2712
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
| $56.6K | ﹤0.01% |
1,349
-1,594
| -54% | -$66.9K |
|
|
PCSB
2713
DELISTED
PCSB Financial Corporation
PCSB
| $56.6K | ﹤0.01% |
2,965
+753
| +34% | +$14.4K |
|
2714
Identive
INVE
$87.5M
| $56.5K | ﹤0.01% |
4,879
+2,988
| +158% | +$34.6K |
|
|
GBL
2715
DELISTED
GAMCO Investors, Inc.
GBL
| $56.4K | ﹤0.01% |
2,700
+2,261
| +515% | +$47.3K |
|
2716
First Western Financial
MYFW
$228M
| $56.2K | ﹤0.01% |
2,067
+2,017
| +4,034% | +$54.8K |
|
2717
UBS Group
UBS
$130B
| $55.6K | ﹤0.01% |
3,426
-2,005
| -37% | -$32.5K |
|
2718
Superior Group of Companies
SGC
$196M
| $55.4K | ﹤0.01% |
3,121
+1,263
| +68% | +$22.4K |
|
|
SRG
2719
Seritage Growth Properties
SRG
$247M
| $55.3K | ﹤0.01% |
10,605
-22,532
| -68% | -$117K |
|
2720
Nathan's Famous
NATH
$452M
| $55.1K | ﹤0.01% |
941
+645
| +218% | +$37.8K |
|
2721
Parke Bancorp
PKBK
$268M
| $54.6K | ﹤0.01% |
2,607
+2,571
| +7,142% | +$53.9K |
|
|
SVM
2722
Silvercorp Metals
SVM
$1.13B
| $54.6K | ﹤0.01% |
22,024
-11,780
| -35% | -$29.2K |
|
2723
Xoma
XOMA
$456M
| $54.6K | ﹤0.01% |
2,449
+1,102
| +82% | +$24.6K |
|
2724
GeoPark
GPRK
$331M
| $54.3K | ﹤0.01% |
+4,200
| New | +$54.3K |
|
2725
Seres Therapeutics
MCRB
$154M
| $54.1K | ﹤0.01% |
789
-1,549
| -66% | -$106K |
|